1. First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advanced solid tumors. Issue 1 (December 2016) Authors: Li, Tianhong; LoRusso, Patricia; Maitland, Michael; Ou, Sai-Hong; Bahceci, Erkut; Ball, Howard; Park, Jung; Yuen, Geoffrey; Tolcher, Anthony Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improving attribution of adverse events in oncology clinical trials. (June 2019) Authors: George, Goldy C.; Barata, Pedro C.; Campbell, Alicyn; Chen, Alice; Cortes, Jorge E.; Hyman, David M.; Jones, Lee; Karagiannis, Thomas; Klaar, Sigrid; Le-Rademacher, Jennifer G.; LoRusso, Patricia; Mandrekar, Sumithra J.; Merino, Diana M.; Minasian, Lori M.; Mitchell, Sandra A.; Montez, Sandra; O'... Journal: Cancer treatment reviews Issue: Volume 76(2019) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study. Issue 9 (30th October 2018) Authors: Munster, Pamela; Krop, Ian; LoRusso, Patricia; Ma, Cynthia; Siegel, Barry; Shields, Anthony; Molnár, István; Wickham, Thomas; Reynolds, Joseph; Campbell, Karen; Hendriks, Bart; Adiwijaya, Bambang; Geretti, Elena; Moyo, Victor; Miller, Kathy Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors. Issue 1 (25th May 2018) Authors: Shapiro, Geoffrey I.; Kristeleit, Rebecca S.; Burris, Howard A.; LoRusso, Patricia; Patel, Manish R.; Drew, Yvette; Giordano, Heidi; Maloney, Lara; Watkins, Simon; Goble, Sandra; Jaw‐Tsai, Sarah; Xiao, Jim J. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 1(2019) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC). (10th December 2020) Authors: Lee, Keun-Wook; Chung, Hyun; Kim, Won Seog; Chow, Laura; Lakhani, Nehal; Messersmith, Wells; Bang, Yung-Jue; LoRusso, Patricia; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Forgie, Alison; Wan, Hong; Pons, Jaume; Randolph, Sophia; Gainor, Justin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 807 A multicenter open-label phase I/lb study of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors. (9th November 2020) Authors: Marabelle, Aurelien; Champiat, Stephane; Garralda, Elena; Hernando, Alberto; Janku, Filip; Raina, Anjali; Sachse, Richard; Bechard, David; Krasnopolskaya, Inna; Ferrara, Stefano; LoRusso, Patricia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors. (10th December 2020) Authors: Garralda, Elena; Geva, Ravit; Ben-Ami, Eytan; Maurice-Dror, Corinne; Calvo, Emiliano; LoRusso, Patricia; Türeci, Özlem; Niewood, Michelle; Şahin, Uğur; Jure-Kunkel, Maria; Forssmann, Ulf; Ahmadi, Tahamtan; Melero, Ignacio Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Issue 10241 (20th June 2020) Authors: Kuderer, Nicole M; Choueiri, Toni K; Shah, Dimpy P; Shyr, Yu; Rubinstein, Samuel M; Rivera, Donna R; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; de Lima Lopes, Gilberto; Grivas, Petros; Painter, Corrie A; Peters, Solange; Thompson, Michael A; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; ... Journal: Lancet Issue: Volume 395:Issue 10241(2020) Page Start: 1907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations. (8th August 2019) Authors: Bardia, Aditya; Gounder, Mrinal; Rodon, Jordi; Janku, Filip; Lolkema, Martijn P.; Stephenson, Joe J.; Bedard, Philippe L.; Schuler, Martin; Sessa, Cristiana; LoRusso, Patricia; Thomas, Michael; Maacke, Heiko; Evans, Helen; Sun, Yongjian; Tan, Daniel S.W. Journal: Oncologist Issue: Volume 25:Number 1(2020) Page Start: e160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Incidence of Mucositis in Patients Treated With Temsirolimus-Based Regimens and Correlation to Treatment Response. (25th March 2014) Authors: Liu, Xiaochun; LoRusso, Patricia; Mita, Monica; Piha-Paul, Sarina; Hong, David S.; Fu, Siqing; McQuinn, Lacey; Asatiani, Ekaterine; Doyle, Lawrence A.; Chen, Helen X.; Hess, Kenneth R.; Kurzrock, Razelle; Naing, Aung Journal: Oncologist Issue: Volume 19:Number 4(2014) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗